Parkinson’s disease (QS164)

This NICE quality standard was published in February 2018 and covers the management of Parkinson’s disease in adults.

It makes five quality statements:

• Point of contact with specialist services
• Information about impulse control disorders
• Referal to physiotherapy, occupational therapy, or speech and language therapy
• Levodopa in hospital or a care home
• Access to clozapine for treating hallucinations and delusions

For more information please visit the NICE website.